Please use this identifier to cite or link to this item:
https://cris.library.msu.ac.zw//handle/11408/4902
Title: | Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery | Authors: | Rebollo-Lopez, María Jose Lelièvre, Joël Alvarez-Gomez, Daniel Castro-Piche, Julia Martínez-Jiménez, Francisco Papadatos, George Kumar, Vinod Colmenarejo, Gonzalo Mugumbate, Grace Hurle, Mark Barroso, Vanessa Young, Rob J Martinez-Hoyos, María González del Río, Rubén Bates, Robert H Lopez-Roman, Eva Maria Mendoza-Losana, Alfonso Brown, James R Alvarez-Ruiz, Emilio Marti-Renom, Marc A Overington, John P Cammack, Nicholas Ballell, Lluís Barros-Aguire, David |
Keywords: | Mycobacterium tuberculosis Purine metabolism Tuberculosis drug discovery Tuberculosis Metabolic pathways |
Issue Date: | 2015 | Publisher: | Public Library of Science | Source: | Rebollo-Lopez MJ, Lelièvre J, Alvarez-Gomez D, Castro-Pichel J, Martínez-Jiménez F, Papadatos G, et al. (2015) Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery. PLoS ONE 10(12): e0142293. https://doi.org/10.1371/journal.pone.0142293 | Series/Report no.: | PLoS ONE;10(12) | Abstract: | As a follow up to the antimycobacterial screening exercise and the release of GSK´s first Tres Cantos Antimycobacterial Set (TCAMS-TB), this paper presents the results of a second antitubercular screening effort of two hundred and fifty thousand compounds recently added to the GSK collection. The compounds were further prioritized based on not only antitubercular potency but also on physicochemical characteristics. The 50 most attractive compounds were then progressed for evaluation in three different predictive computational biology algorithms based on structural similarity or GSK historical biological assay data in order to determine their possible mechanisms of action. This effort has resulted in the identification of novel compounds and their hypothesized targets that will hopefully fuel future TB drug discovery and target validation programs alike. | URI: | https://doi.org/10.1371/journal.pone.0142293 http://hdl.handle.net/11408/4902 |
ISSN: | 1932-6203 |
Appears in Collections: | Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
RELEASE OF 50.pdf | Full Text.pdf | 1.75 MB | Adobe PDF | View/Open |
Page view(s)
18
checked on Aug 30, 2024
Download(s)
10
checked on Aug 30, 2024
Google ScholarTM
Check
Items in MSUIR are protected by copyright, with all rights reserved, unless otherwise indicated.